Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119982) titled 'Clinical trial on the Efficacy and Safety of an IL-1 Inhibitor in Elderly Patients With Gouty Arthritis' on March 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Hebei General Hospital
Condition:
Gouty Arthritis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-20
Target Sample Size: Treatment group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311470
Published by HT Digital Content Services with permission from Health Daily Digest....